Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
3.000
+0.030 (1.01%)
Sep 4, 2025, 4:00 PM - Market closed
Galecto Market Cap
Galecto has a market cap or net worth of $3.97 million as of September 4, 2025. Its market cap has decreased by -74.76% in one year.
Market Cap
3.97M
Enterprise Value
-6.16M
1-Year Change
-74.76%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $3.97M, a decrease of -98.92%. That is a compound annual growth rate of -60.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 3.93M | -35.76% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | 368.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |